Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MARUHO CO.,LTD.

Home Clinical Trial Sponsors and OrganizationsMARUHO CO.,LTD.

MARUHO CO.,LTD.

1005, YASHIMAMACHI, NISHI-KU, Kumamoto, Japan

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

109

18 active

Approvals

2

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

40

36.7%

Phase 2

27

24.8%

Phase 1

7

6.4%

Not Applicable

1

0.9%

Trial Status Distribution

Active, not recruiting

17

15.6%

Completed

45

41.3%

Not yet recruiting

1

0.9%

Recruiting

4

3.7%

Clinical Trials

Trials sponsored by this organization (109)

A Phase II, randomized, placebo-controlled, double-blind, parallel-group, dose-finding, multicenter study to evaluate the efficacy and safety of nemolizumab in subjects with chronic pruritus of unknown origin

Feb 202562 participants

Single and multiple dose study of M136101 in healthy subjects.

Active, not recruiting

Nov 202424 participants

A Phase 2, Randomized, Placebo-controlled, Double-Blind, Parallel Group, Multi-Center Study to Evaluate Efficacy and Safety of M127101 in Subjects with Nasal polyp associated with Eosinophilic Chronic Rhinosinusitis

Active, not recruiting

May 202445 participants

Single ascending dose and multiple ascending dose study of M132101 in healthy subjects.

Active, not recruiting

Mar 202448 participants

Single-dose study of M707102 in healthy subjects

Feb 202416 participants

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Nemolizumab in Patients with Acquired Reactive Perforating Collagenosis

Dec 202321 participants

The phase 4 study of the tacrolimus ointment 0.03% in Infant and toddler patients with Atopic dermatitis

Active, not recruiting

Oct 202320 participants

A single and multiple dose study of M127101 in healthy subjects

Jun 202316 participants

Page 1 of 14

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

2

Approvals

Recent Approvals

Pediatric Faropenem Sodium Granules

Pediatric Faropenem Sodium Granules

News

No news articles found

On this page

Overview
Clinical Trials109
Approvals2
News

Back to Organizations